+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Polymerase Chain Reaction Market by Product (Consumables & Reagents, Instruments, Software & Services), Technology (Digital PCR, Real-time PCR, Traditional PCR), Application, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 192 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5666542
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Polymerase Chain Reaction Market size was estimated at USD 9.08 billion in 2023, USD 10.20 billion in 2024, and is expected to grow at a CAGR of 12.57% to reach USD 20.82 billion by 2030.

Polymerase chain reaction (PCR) is a increasingly used technique in modern biology for in-vitro amplification and generating several copies of a specific region in a DNA strand. Increasing research and development (R&D) activities in advanced molecular biology and forensic science, rising demand for personalized medicines, and advancement in genetic engineering are projected to drive the demand for polymerase chain reaction instruments. The demand for polymerase chain reaction systems is increasing in the food industry to detect pathogenic microorganisms and identify allergens. However, the high cost and technical limitations associated with polymerase chain reaction impede the market's growth. The introduction of highly sensitive and optimized polymerase chain reaction instruments by market vendors is expected to fuel the market's growth.

Regional Insights

The Americas represents a highly developing and innovative landscape for the global polymerase chain reaction market characterized by rising awareness and market players' increasing introduction of advanced polymerase chain reaction systems. In August 2022, GenScript USA launched a real-time polymerase chain reaction (RT-PCR) monkeypox test for research lab use. Significant governmental initiatives and investments to expand biotechnology research and development with advanced analytical equipment are expected to foster the growth of the polymerase chain reaction market. In May 2021, the Australian Government committed USD 206.4 million to a patent box tax incentive scheme to encourage investment in Australia's biotechnology and medical technology sectors. Asia's vast population, focus on investments in specialized clinical trial centers, and government support for clinical trials are significant factors in the region's reputation as a hub for successful clinical trials. The polymerase chain reaction market witnessed substantial growth in Europe, the middle east, and African (EMEA) regions owing to the ongoing development of the life science industry. According to the United Kingdom Government, the country's healthy life science sector contributes more than USD 66 billion and 220,000 jobs annually to the UK economy.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Polymerase Chain Reaction Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Polymerase Chain Reaction Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Polymerase Chain Reaction Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 3M Company, Abbott Laboratories, ACON Laboratories, Inc., Agilent Technologies, Inc., Azure Biosystems Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux, S.A., Danaher Corporation, Eppendorf SE, F. Hoffmann-La Roche Ltd., Fluidigm Corporation, GeneCopoeia, Inc., Illumina, Inc., JN Medsys Pte. Ltd., Kawasaki Heavy Industries, Ltd., KYORIN Pharmaceutical Co., Ltd., LabTurbo Biotech Corporation, LGC Limited, MBS Molecular Biology Systems, Merck KGaA, Microsynth AG, Molbio Diagnostics Pvt. Ltd., Ningbo Scientz Biotechnology Co., Ltd., Promega Corporation, Shimadzu Corporation, Siemens AG, Standard BioTools, Stilla Technologies, Stilla Technologies Inc., SV SCIENTIFIC PRIVATE LIMITED, Sysmex AG, Takara Bio Inc., Thermo Fisher Scientific, Inc., and VWR International, LLC by Avantor, Inc.

Market Segmentation & Coverage

This research report categorizes the Polymerase Chain Reaction Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables & Reagents
    • Instruments
    • Software & Services
  • Technology
    • Digital PCR
    • Real-time PCR
    • Traditional PCR
  • Application
    • Medical
      • Clinical
        • Blood screening
        • Oncology testing
        • Pathology testing
      • Forensics
      • Research
    • Non-Medical
      • Agriculture
      • Food
  • End-User
    • Academic Research Institutes
    • Biotechnology Companies
    • Contract Research Organization/ Contract Manufacturing Organization
    • Diagnostic Laboratories
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Polymerase Chain Reaction Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Polymerase Chain Reaction Market?
  3. What are the technology trends and regulatory frameworks in the Polymerase Chain Reaction Market?
  4. What is the market share of the leading vendors in the Polymerase Chain Reaction Market?
  5. Which modes and strategic moves are suitable for entering the Polymerase Chain Reaction Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Polymerase Chain Reaction Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the prevalence of infectious diseases, cancer, and genetic disease
5.1.1.2. Increasing life science and biopharmaceutical research and development activities
5.1.1.3. Growing demand in the food & beverage industry
5.1.2. Restraints
5.1.2.1. High cost associated with a polymer chain reaction
5.1.3. Opportunities
5.1.3.1. Introduction of high sensitive and optimized polymer chain reaction instruments
5.1.3.2. Technological advancements in molecular biology, life sciences, and biotechnology
5.1.4. Challenges
5.1.4.1. Technical limitations of polymer chain reaction systems
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Polymerase Chain Reaction Market, by Product
6.1. Introduction
6.2. Consumables & Reagents
6.3. Instruments
6.4. Software & Services
7. Polymerase Chain Reaction Market, by Technology
7.1. Introduction
7.2. Digital PCR
7.3. Real-time PCR
7.4. Traditional PCR
8. Polymerase Chain Reaction Market, by Application
8.1. Introduction
8.2. Medical
8.3.1. Clinical
8.3.2.1. Blood screening
8.3.2.2. Oncology testing
8.3.2.3. Pathology testing
8.3.2. Forensics
8.3.3. Research
8.3. Non-Medical
8.4.1. Agriculture
8.4.2. Food
9. Polymerase Chain Reaction Market, by End-User
9.1. Introduction
9.2. Academic Research Institutes
9.3. Biotechnology Companies
9.4. Contract Research Organization/ Contract Manufacturing Organization
9.5. Diagnostic Laboratories
9.6. Hospitals
10. Americas Polymerase Chain Reaction Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Polymerase Chain Reaction Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Polymerase Chain Reaction Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Agreement, Collaboration, & Partnership
13.3.1.1. Genomadix Inc. announces know-how license agreement with Mayo Clinic
13.3.2. New Product Launch & Enhancement
13.3.2.1. Next Generation of qPCR Reagents push the boundaries of performance
13.3.2.2. Roche introduces the cobas 5800, a new molecular diagnostic system to expand access to PCR testing in the U.S.
13.3.2.3. Bosch’s Vivalytic platform offering new PCR rapid test for MRSA
13.3.2.4. GenScript launches monkeypox PCR test
13.3.3. Investment & Funding
13.3.3.1. Mumbai-based Rivaara Labs raises funding from Amicus, Kotak investment advisors
13.3.3.2. Molbio Diagnostics raises $85 mn from Temasek at unicorn valuation
13.3.3.3. Zymo Research to invest in Star Array for PCR platform development
13.3.3.4. North York life sciences company gets $2.5M from provincial fund to help produce PCR test chemicals
13.3.4. Award, Recognition, & Expansion
13.3.4.1. Roche expands the COVID-19 PCR test portfolio to the new cobas 5800 System in countries accepting the CE Mark
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. 10x Genomics, Inc.
14.1.2. 3M Company
14.1.3. Abbott Laboratories
14.1.4. ACON Laboratories, Inc.
14.1.5. Agilent Technologies, Inc.
14.1.6. Azure Biosystems Inc.
14.1.7. Becton, Dickinson and Company
14.1.8. Bio-Rad Laboratories, Inc.
14.1.9. bioMérieux, S.A.
14.1.10. Danaher Corporation
14.1.11. Eppendorf SE
14.1.12. F. Hoffmann-La Roche Ltd.
14.1.13. Fluidigm Corporation
14.1.14. GeneCopoeia, Inc.
14.1.15. Illumina, Inc.
14.1.16. JN Medsys Pte. Ltd.
14.1.17. Kawasaki Heavy Industries, Ltd.
14.1.18. KYORIN Pharmaceutical Co., Ltd.
14.1.19. LabTurbo Biotech Corporation
14.1.20. LGC Limited
14.1.21. MBS Molecular Biology Systems
14.1.22. Merck KGaA
14.1.23. Microsynth AG
14.1.24. Molbio Diagnostics Pvt. Ltd.
14.1.25. Ningbo Scientz Biotechnology Co., Ltd.
14.1.26. Promega Corporation
14.1.27. Shimadzu Corporation
14.1.28. Siemens AG
14.1.29. Standard BioTools
14.1.30. Stilla Technologies
14.1.31. Stilla Technologies Inc.
14.1.32. SV SCIENTIFIC PRIVATE LIMITED
14.1.33. Sysmex AG
14.1.34. Takara Bio Inc.
14.1.35. Thermo Fisher Scientific, Inc.
14.1.36. VWR International, LLC by Avantor, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. POLYMERASE CHAIN REACTION MARKET RESEARCH PROCESS
FIGURE 2. POLYMERASE CHAIN REACTION MARKET SIZE, 2022 VS 2030
FIGURE 3. POLYMERASE CHAIN REACTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. POLYMERASE CHAIN REACTION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. POLYMERASE CHAIN REACTION MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. POLYMERASE CHAIN REACTION MARKET DYNAMICS
FIGURE 7. POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 10. POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 12. POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 14. POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. POLYMERASE CHAIN REACTION MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. POLYMERASE CHAIN REACTION MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. POLYMERASE CHAIN REACTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. POLYMERASE CHAIN REACTION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. POLYMERASE CHAIN REACTION MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. POLYMERASE CHAIN REACTION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. POLYMERASE CHAIN REACTION MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 10. POLYMERASE CHAIN REACTION MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. POLYMERASE CHAIN REACTION MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. POLYMERASE CHAIN REACTION MARKET SIZE, BY TRADITIONAL PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 14. POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 16. POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 18. POLYMERASE CHAIN REACTION MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. POLYMERASE CHAIN REACTION MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. POLYMERASE CHAIN REACTION MARKET SIZE, BY PATHOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. POLYMERASE CHAIN REACTION MARKET SIZE, BY FORENSICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. POLYMERASE CHAIN REACTION MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 25. POLYMERASE CHAIN REACTION MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. POLYMERASE CHAIN REACTION MARKET SIZE, BY FOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. POLYMERASE CHAIN REACTION MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. POLYMERASE CHAIN REACTION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. POLYMERASE CHAIN REACTION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION/ CONTRACT MANUFACTURING ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. POLYMERASE CHAIN REACTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. POLYMERASE CHAIN REACTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 43. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 59. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 60. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 61. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 66. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 67. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 68. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 82. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 89. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 90. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 91. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 96. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 97. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 98. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 103. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 104. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 105. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 108. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 110. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 111. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 112. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 114. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 117. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 118. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 119. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 124. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 125. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 126. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 131. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 132. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 133. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 135. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 136. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 138. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 139. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 140. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 142. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 145. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 146. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 147. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 152. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 153. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 154. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 155. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 156. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 159. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 160. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 161. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 166. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 167. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 168. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 177. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 178. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 181. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 182. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 183. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 185. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 187. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 188. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 189. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 190. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 195. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 196. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 197. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 202. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 203. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 204. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 206. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 207. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 208. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 209. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 210. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 211. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 212. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 213. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 214. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 216. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 217. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 218. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 219. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 220. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 223. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 224. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 225. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 230. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 231. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 232. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 240. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 241. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 244. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 245. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 246. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 247. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 248. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 251. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 252. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 253. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 254. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 255. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 256. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 257. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 258. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 259. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 260. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 268. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 270. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 272. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 274. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 278. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 280. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 282. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 283. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 286. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 287. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 288. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 289. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 290. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 292. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 293. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 294. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 295. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 300. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 301. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 302. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 303. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 304. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 305. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 307. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 308. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 309. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 317. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 318. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 319. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 320. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
TABLE 321. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
TABLE 322. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
TABLE 323. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 324. POLYMERASE CHAIN REACTION MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 325. POLYMERASE CHAIN REACTION MARKET SHARE, BY KEY PLAYER, 2022
TABLE 326. POLYMERASE CHAIN REACTION MARKET LICENSE & PRICING

Companies Mentioned

  • 10x Genomics, Inc.
  • 3M Company
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Azure Biosystems Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux, S.A.
  • Danaher Corporation
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd.
  • Fluidigm Corporation
  • GeneCopoeia, Inc.
  • Illumina, Inc.
  • JN Medsys Pte. Ltd.
  • Kawasaki Heavy Industries, Ltd.
  • KYORIN Pharmaceutical Co., Ltd.
  • LabTurbo Biotech Corporation
  • LGC Limited
  • MBS Molecular Biology Systems
  • Merck KGaA
  • Microsynth AG
  • Molbio Diagnostics Pvt. Ltd.
  • Ningbo Scientz Biotechnology Co., Ltd.
  • Promega Corporation
  • Shimadzu Corporation
  • Siemens AG
  • Standard BioTools
  • Stilla Technologies
  • Stilla Technologies Inc.
  • SV SCIENTIFIC PRIVATE LIMITED
  • Sysmex AG
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • VWR International, LLC by Avantor, Inc.

Methodology

Loading
LOADING...

Table Information